MedPath

Implementation of first-trimester screening and prevention of preeclampsia (FORECAST)

Completed
Conditions
High-risk pregnancy for preterm-preeclampsia identified by screening at 11-13 weeks
Registration Number
jRCTs041190035
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
7800
Inclusion Criteria

Singleton pregnancy

Exclusion Criteria

Multiple pregnancy, Major fetal defects identified at 11-13 weeks of assessment, Non-viable fetus

Study & Design

Study Type
Interventional
Study Design
parallel assignment
Primary Outcome Measures
NameTimeMethod
-

Delivery with preeclampsia at < 37 weeks of gestation

Secondary Outcome Measures
NameTimeMethod
Abnormal pregnancy outcome at less than 34 weeks of gestationless than 34 weeks of gestation

Abnormal pregnancy outcome (preeclampsia, gestational hypertension, low birth weight infant (SGA; less than 5th percentile of birth weight), stillbirth, placental abruption)

Abnormal pregnancy outcome at 34 to 37 weeks of gestation34 to 37 weeks of gestation

Abnormal pregnancy outcome (preeclampsia, gestational hypertension, low birth weight infant (SGA; less than 5th percentile of birth weight), stillbirth, placental abruption)

Abnormal pregnancy outcome at 37 weeks of gestation or later37 weeks of gestation or later

Abnormal pregnancy outcome (preeclampsia, gestational hypertension, low birth weight infant (SGA; less than 5th percentile of birth weight), stillbirth, placental abruption)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.